WallStreetZenWallStreetZen

NYSE: BHC
Bausch Health Companies Inc Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for BHC

Based on 3 analysts offering 12 month price targets for Bausch Health Companies Inc.
Min Forecast
$6.00-19.25%
Avg Forecast
$7.33-1.31%
Max Forecast
$8.00+7.67%

Should I buy or sell BHC stock?

Based on 5 analysts offering ratings for Bausch Health Companies Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
5 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BHC stock forecasts and price targets.

BHC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Piper Sandler
Top 14%
87
HoldMaintains$6.00-19.25%2022-09-09
RBC Capital
Bottom 3%
3
HoldMaintains$8.00+7.67%2022-09-01
BMO Capital
Bottom 14%
14
HoldMaintains$8.00+7.67%2022-08-10
JP Morgan
Bottom 21%
21
HoldDowngradesN/AN/A2022-07-29
Truist Securities
Bottom 13%
13
HoldDowngradesN/AN/A2022-07-29

1 of 1

Forecast return on equity

Is BHC forecast to generate an efficient return?
Company
-400.47%
Industry
26.53%
Market
62.84%
BHC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BHC forecast to generate an efficient return on assets?
Company
7.99%
Industry
13.42%
BHC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BHC earnings per share forecast

What is BHC's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$3.41+380.28%
Avg 2 year Forecast
$3.98+460.56%
Avg 3 year Forecast
$5.07+614.08%
BHC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

BHC revenue forecast

What is BHC's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$8.3B+1.61%
Avg 2 year Forecast
$8.6B+5.42%
Avg 3 year Forecast
$8.9B+9.48%
BHC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BHC earnings growth forecast

How is BHC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
91.04%
Industry
14.93%
Market
17.02%
BHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
BHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
BHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

BHC revenue growth forecast

How is BHC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
3.05%
Industry
3.68%
Market
6.69%
BHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BHC vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
BHC$7.43$7.33-1.31%Hold
EVO$8.32$16.00+92.31%Strong Sell
TLRY$4.06$3.91-3.60%Hold
PCRX$46.97$75.00+59.68%Buy
SUPN$35.60$38.00+6.74%Strong Buy
View Top Pharmaceutical Stocks

Bausch Health Companies Stock Forecast FAQ

Is Bausch Health Companies Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NYSE: BHC) stock is to Hold BHC stock.

Out of 5 analysts, 0 (0%) are recommending BHC as a Strong Buy, 0 (0%) are recommending BHC as a Buy, 5 (100%) are recommending BHC as a Hold, 0 (0%) are recommending BHC as a Sell, and 0 (0%) are recommending BHC as a Strong Sell.

If you're new to stock investing, here's how to buy Bausch Health Companies stock.

What is BHC's earnings growth forecast for 2022-2024?

(NYSE: BHC) Bausch Health Companies's forecast annual earnings growth rate of 91.04% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 14.93%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Bausch Health Companies's earnings in 2022 is $254,000,000.On average, 6 Wall Street analysts forecast BHC's earnings for 2022 to be $1,233,970,327, with the lowest BHC earnings forecast at $868,483,514, and the highest BHC earnings forecast at $1,440,235,161. On average, 6 Wall Street analysts forecast BHC's earnings for 2023 to be $1,440,235,161, with the lowest BHC earnings forecast at $958,950,547, and the highest BHC earnings forecast at $1,686,305,490.

In 2024, BHC is forecast to generate $1,834,671,424 in earnings, with the lowest earnings forecast at $1,679,068,128 and the highest earnings forecast at $1,899,807,688.

What is BHC's revenue growth forecast for 2022-2024?

(NYSE: BHC) Bausch Health Companies's forecast annual revenue growth rate of 3.05% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.69%.

Bausch Health Companies's revenue in 2022 is $8,127,000,000.On average, 4 Wall Street analysts forecast BHC's revenue for 2022 to be $2,988,157,574,260, with the lowest BHC revenue forecast at $2,944,911,799,528, and the highest BHC revenue forecast at $3,009,440,124,648. On average, 4 Wall Street analysts forecast BHC's revenue for 2023 to be $3,100,399,298,057, with the lowest BHC revenue forecast at $3,071,511,365,159, and the highest BHC revenue forecast at $3,142,538,841,912.

In 2024, BHC is forecast to generate $3,219,723,504,913 in revenue, with the lowest revenue forecast at $3,165,332,915,483 and the highest revenue forecast at $3,301,315,721,750.

What is BHC's forecast return on assets (ROA) for 2022-2025?

(NYSE: BHC) forecast ROA is 7.99%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 13.42%.

What is BHC's Price Target?

According to 3 Wall Street analysts that have issued a 1 year BHC price target, the average BHC price target is $7.33, with the highest BHC stock price forecast at $8.00 and the lowest BHC stock price forecast at $6.00.

On average, Wall Street analysts predict that Bausch Health Companies's share price could fall to $7.33 by Sep 9, 2023. The average Bausch Health Companies stock price prediction forecasts a potential downside of 1.31% from the current BHC share price of $7.43.

What is BHC's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: BHC) Bausch Health Companies's current Earnings Per Share (EPS) is $0.71. On average, analysts forecast that BHC's EPS will be $3.41 for 2022, with the lowest EPS forecast at $2.40, and the highest EPS forecast at $3.98. On average, analysts forecast that BHC's EPS will be $3.98 for 2023, with the lowest EPS forecast at $2.65, and the highest EPS forecast at $4.66. In 2024, BHC's EPS is forecast to hit $5.07 (min: $4.64, max: $5.25).

What is BHC's forecast return on equity (ROE) for 2022-2025?

(NYSE: BHC) forecast ROE is -400.47%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.